Literature DB >> 20937561

Halogenation of 4-hydroxy/amino-3-methoxyphenyl acetamide TRPV1 agonists showed enhanced antagonism to capsaicin.

Dong Wook Kang1, Yong Soo Kim, Kwang Su Lim, Myeong Seop Kim, Larry V Pearce, Vladimir A Pavlyukovets, Andy K Tao, Krystle A Lang-Kuhs, Peter M Blumberg, Jeewoo Lee.   

Abstract

As an extension of our analysis of the effect of halogenation on thiourea TRPV1 agonists, we have now modified selected 4-hydroxy(or 4-amino)-3-methoxyphenyl acetamide TRPV1 agonists by 5- or 6-halogenation on the aromatic A-region and evaluated them for potency for TRPV1 binding and regulation and for their pattern of agonism/antagonism (efficacy). Halogenation shifted the functional activity at TRPV1 toward antagonism with a greater extent of antagonism as the size of the halogen increased (I>Br>Cl), as previously observed for the thiourea series. The extent of antagonism was greater for halogenation at the 5-position than at the 6-position, in contrast to SAR for the thiourea series. In this series, compounds 55 and 75 showed the most potent antagonism, with K(i) (ant)=2.77 and 2.19nM, respectively, on rTRPV1 expressed in Chinese hamster ovary cells. The compounds were thus ca. 40-60-fold more potent than 6'-iodononivamide.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20937561      PMCID: PMC3420354          DOI: 10.1016/j.bmc.2010.09.001

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  21 in total

1.  Halogenation of 4-hydroxy-3-methoxybenzyl thiourea TRPV1 agonists showed enhanced antagonism to capsaicin.

Authors:  Dong Wook Kang; Hyungchul Ryu; Jeewoo Lee; Krystle A Lang; Vladimir A Pavlyukovets; Larry V Pearce; Tetsurou Ikeda; Jozsef Lazar; Peter M Blumberg
Journal:  Bioorg Med Chem Lett       Date:  2006-10-10       Impact factor: 2.823

Review 2.  The potential of transient receptor potential vanilloid type 1 channel modulators for the treatment of pain.

Authors:  Susan M Westaway
Journal:  J Med Chem       Date:  2007-05-10       Impact factor: 7.446

Review 3.  Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: Recent advances and setbacks.

Authors:  Gilbert Y Wong; Narender R Gavva
Journal:  Brain Res Rev       Date:  2008-12-25

4.  Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances.

Authors:  S W Hwang; H Cho; J Kwak; S Y Lee; C J Kang; J Jung; S Cho; K H Min; Y G Suh; D Kim; U Oh
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

5.  The taming of capsaicin. Reversal of the vanilloid activity of N-acylvanillamines by aromatic iodination.

Authors:  Giovanni Appendino; Nives Daddario; Alberto Minassi; Aniello Schiano Moriello; Luciano De Petrocellis; Vincenzo Di Marzo
Journal:  J Med Chem       Date:  2005-07-14       Impact factor: 7.446

Review 6.  Transient receptor potential ion channels as targets for the discovery of pain therapeutics.

Authors:  James E Krause; Bertrand L Chenard; Daniel N Cortright
Journal:  Curr Opin Investig Drugs       Date:  2005-01

7.  Iodo-resiniferatoxin, a new potent vanilloid receptor antagonist.

Authors:  P Wahl; C Foged; S Tullin; C Thomsen
Journal:  Mol Pharmacol       Date:  2001-01       Impact factor: 4.436

Review 8.  The paradoxical role of the transient receptor potential vanilloid 1 receptor in inflammation.

Authors:  Khadija Alawi; Julie Keeble
Journal:  Pharmacol Ther       Date:  2009-11-05       Impact factor: 12.310

Review 9.  The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept.

Authors:  Arpad Szallasi; Daniel N Cortright; Charles A Blum; Samer R Eid
Journal:  Nat Rev Drug Discov       Date:  2007-05       Impact factor: 84.694

Review 10.  Clinical development of TRPV1 antagonists: targeting a pivotal point in the pain pathway.

Authors:  Martin J Gunthorpe; Boris A Chizh
Journal:  Drug Discov Today       Date:  2008-12-26       Impact factor: 7.851

View more
  2 in total

1.  Design, synthesis, and biological evaluation of indenoisoquinoline rexinoids with chemopreventive potential.

Authors:  Martin Conda-Sheridan; Eun-Jung Park; Daniel E Beck; P V Narasimha Reddy; Trung X Nguyen; Bingjie Hu; Lian Chen; Jerry J White; Richard B van Breemen; John M Pezzuto; Mark Cushman
Journal:  J Med Chem       Date:  2013-03-08       Impact factor: 7.446

2.  The SAR analysis of TRPV1 agonists with the α-methylated B-region.

Authors:  Yongsung Cho; Myeong Seop Kim; Ho Shin Kim; Jihyae Ann; Jiyoun Lee; Larry V Pearce; Vladimir A Pavlyukovets; Matthew A Morgan; Peter M Blumberg; Jeewoo Lee
Journal:  Bioorg Med Chem Lett       Date:  2012-06-23       Impact factor: 2.823

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.